PCRX Pacira Biosciences, Inc.

$22.29 -1.55%

Healthcare · Pharmaceutical Preparations

Pacira Biosciences, Inc. (PCRX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $877 million. Shares last traded at $22.29, 23.1% below their 52-week high. Over the past year the stock is down 8.7%. PCRX trades at a price-to-earnings ratio of 125.30, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 1.0%, above the peer median of -0.1%. Revenue grew 3.6% year over year.

Market Cap

$877M

Shares Out

39.3M

EPS (TTM)

$0.29

P/E Ratio

76.86

P/S Ratio

1.21

P/B Ratio

1.34

Dividend / Share

—

Dividend Yield

—

52-Week High

$29.00

52-Week Low

$17.99

Volume

17,446

Avg Vol (3m)

28,612.349

Performance

-4.60%

-0.13%

-1.11%

-14.86%

YTD

-8.87%

-8.68%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

40.52

SMA (50)

$23.60

SMA (200)

$23.49

Price vs SMA50

-5.57%

Price vs SMA200

-5.12%

ATR (14)

$1.50

Financials

Revenue

$726M

Net Income

$7M

Gross Margin

—

Operating Margin

2.6%

Net Margin

1.0%

Return on Equity

1.1%

Return on Assets

0.6%

Current Ratio

4.73

Debt / Equity

0.56

Revenue Growth (YoY)

+3.6%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.07	2026-04-30
FY 2025	$0.16	2026-02-26
Q3 2025	$0.12	2025-11-06
Q2 2025	$0.00	2025-08-05
Q1 2026	$0.10	2026-04-30
FY 2025	$-2.15	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

PCRX vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

125.30 / 16.82 med

+645% premium

P/S vs peers

1.21 / 3.54 med

-66% discount

Net margin vs peers

1.0% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.